HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ICI 195739

structure given in first source
Also Known As:
2-(2,4-difluorophenyl)-1-(3-(4-(2,2,3,3-tetrafluoropropoxy)styryl)-1,2,4-triazol-1-yl)-3-(1,2,4-triazol-1-yl)propan-2-ol; D 0870; D-0870; D0870; DO870; ICI 195,739; ICI-195739; 1H-1,2,4-Triazole-1-ethanol, alpha-(2,4-difluorophenyl)-3-(2-(4-(2,2,3,3-tetrafluoropropoxy)phenyl)ethenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-
Networked: 30 relevant articles (14 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Brener, Z: 2 articles (01/2001 - 07/2000)
2. Molina, J: 2 articles (01/2001 - 07/2000)
3. Mitsui, T: 2 articles (05/2000 - 04/2000)
4. Harada, T: 2 articles (05/2000 - 04/2000)
5. Shibutani, Y: 2 articles (05/2000 - 04/2000)
6. Murano, H: 2 articles (05/2000 - 04/2000)
7. Matsunaga, T: 2 articles (05/2000 - 04/2000)
8. Buckner, Frederick S: 1 article (01/2008)
9. Urbina, J: 1 article (01/2001)
10. Rodrigues Júnior JM,: 1 article (01/2001)

Related Diseases

1. Infection
2. Histoplasmosis
3. Candidiasis (Moniliasis)
4. Acquired Immunodeficiency Syndrome (AIDS)
5. Chagas Disease (American Trypanosomiasis)

Related Drugs and Biologics

1. Fluconazole (Zonal)
2. Dihydrotachysterol (AT 10)
3. Amphotericin B (Amphotericin)
4. Itraconazole (Sporanox)
5. Ketoconazole (Nizoral)
6. Flucytosine (Ancobon)
7. posaconazole
8. Catecholamines
9. Estrogens (Estrogen)
10. Cyclophosphamide (Cytoxan)

Related Therapies and Procedures

1. Oral Administration
2. Nanospheres